Effectiveness and safety of the Xuefu Zhuyu Tang for post-stroke depression: A systematic review and meta-analysis

Jingyi Shao,Lingming Zhou,Tianyu Shao,Minrui Ding,Zhuqing Jin
DOI: https://doi.org/10.1016/j.eujim.2020.101150
IF: 1.813
2020-08-01
European Journal of Integrative Medicine
Abstract:IntroductionZeroWidthSpace;Feelings of depression are common after a stroke. Xuefu Zhuyu Tang (XFZYT) is Chinese formula of 11 herbs which is used in Clinical practice in China for post-stroke depression (PSD). This systematic review and meta-analysis evaluated the efficacy and safety of XFZYT alone or in combination with antidepressants for the treatment of PSD.MethodsEight electronic databases including PubMed, Web of Science, the Cochrane Library, EBSCO, CNKI (China National Knowledge Infrastructure), CBM (Chinese Biomedicine Database), WanFang, and VIP (Chinese Scientific Journals Database) were searched for randomized controlled trials (RCTs) on XFZYT or XFZYT combined with an antidepressant. The data were analyzed by Review Manager version 5.3 software and evaluated by GRADEpro.ResultsA total of 12 RCTs involving 889 patients with PSD were included. The results showed that (1) XFZYT combined with antidepressants alleviated depression measured by the Hamilton Depression Scale (HAMD) (mean difference(MD) =-3.72, 95% confidence interval(CI) =[-4.40,-3.05], I2 = 46%) and the Self-rating depression scale(SDS) (MD =-6.98, 95%CI=[-8.44,-5.53], I2 = 0%), showing higher effective rate based on depression scales (relative rate (RR) = 1.17, 95%CI= [1.06,1.29], I2 = 49%) compared to antidepressants alone. There were no significant differences in terms of Barthel index and adverse events. Adjuvant treatment with XFZYT did not reduce the risk of adverse events caused by antidepressants. (2) There were no significant differences between XFZYT group and antidepressants group in terms of HAMD score (P = 0.22), effective rate (P = 0.46), and Barthel index (P = 0.35). Due to the lack of literature, the safety of XFZYT needed further research. The quality of evidence evaluated by the GRADE approach was rated mostly "Very low" to "Low."ConclusionsThis study provides evidence supporting the view that XFZYT is as effective as antidepressants and may be used for treating PSD in patients who prefer Chinese medicine or cannot tolerate the side effects of antidepressants. Because the quantity and quality of the included studies are limited, the preceding conclusions need further verification through investigations comprising larger and high-quality samples.
integrative & complementary medicine
What problem does this paper attempt to address?